Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Lexicon Genetics granted NIH grant for DNA repair research

Aug. 4, 1997

AEterna reports promising safety profile for Neovastat

July 31, 1997

Potential antitumor agents evaluated by Taiwan researchers

July 31, 1997

Daiichi's new anticancer agent enters overseas clinical trials

July 30, 1997

Inhibitors of cyclin-dependent protein kinases disclosed by CNRS researchers

July 30, 1997

Repligen identifies angiogenic growth factor inhibitors

July 29, 1997

Targeted Genetics cancer gene therapy product approved for European clinical trials

July 28, 1997

Allos Therapeutics reports clinical results of RSR13

July 28, 1997

Known heart failure drug studied for AML

July 28, 1997

Sparta's oral chemotherapeutic agent enters clinical trials

July 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.